Wnt3a but not CDX-2 expression is associated with differentiated thyroid cancer.
Gleyne Lopes Kujew BiaginiCarmen Australia Paredes Marcondes RibasHenrique Diez HigashiVanessa Yumi HirataMaria Augusta Karas ZellaIvan BartolomeiGiuliana BiaginiLuis Martins CollaçoPublished in: Revista da Associacao Medica Brasileira (1992) (2022)
Wnt3a expression but not CDX-2 is correlated with differentiated thyroid cancer samples in comparison to multinodular goiter. Although its prognostic value was limited to tumor size and capsule invasion, a combined model in a panel of immune markers can add accuracy in the classification of challenging thyroid follicular-derived lesions.